Join
Live feed
·
INSIDERFilingvia Quantisnow
PhaseBio Pharmaceuticals Inc. logo

SEC Form 4: Sharp John P was granted 7,500 units of Common Stock, increasing direct ownership by 18% to 50,224 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAS (PhaseBio Pharmaceuticals Inc.) and more on Quantisnow.